WallStSmart
IMMX

Immix Biopharma Inc

NASDAQ: IMMX · HEALTHCARE · BIOTECHNOLOGY

$8.93
+3.48% today

Updated 2026-04-30

Market cap
$505.20M
P/E ratio
P/S ratio
EPS (TTM)
$-0.89
Dividend yield
52W range
$2 – $12
Volume
0.7M

Immix Biopharma Inc (IMMX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-26.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-12.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+11.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
+21.9%
2025-12-03
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-02-25$-0.28-86.7%$8.49$8.49+0.0%
2025-12-03$-0.24-50.0%$3.97$4.84+21.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.15$-0.28-86.7%
2025-09-30$-0.16$-0.24-50.0%
2025-06-30$-0.21$-0.22-4.8%
2025-03-31$-0.23$-0.15+34.8%
2024-12-31$-0.25$-0.25+0.0%$96290.00+1912.8%
2024-09-30$-0.16$-0.24-50.0%
2024-06-30$-0.21$-0.15+28.6%
2024-03-31$-0.23$-0.22+2.4%
2023-12-31$-0.23$-0.23+0.0%$4784.00
2023-09-30$-0.23$-0.23+0.0%
2023-06-30$-0.17$-0.24-41.2%
2023-03-31$-0.14$-0.18-28.6%
2022-12-31$-0.22$-0.27-22.7%

Frequently asked questions

Has Immix Biopharma Inc beaten earnings estimates?
Immix Biopharma Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -26.7% over the last 4 quarters.
How does IMMX stock react to earnings?
IMMX stock has moved an average of +11.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.